Laboratory animals exhibiting obesity and diabetes syndromes

Metabolism

Volumn 26, Issue 1, 1977, Pages 59-99

  Herberg, Lieselotte ^a,b   Coleman, Douglas L ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; ENVIRONMENT; EXPERIMENTAL ANIMAL; GENETICS; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOTHALAMUS; MOUSE; MUTATION; OBESITY; PATHOGENESIS; THEORETICAL STUDY;

ADIPOSE TISSUE; ANIMAL; BLOOD GLUCOSE; BODY WEIGHT; CARBOHYDRATES; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; INSULIN; LIPIDS; MICE; MICE, INBRED STRAINS; MICE, OBESE; MUTATION; OBESITY; OBESITY IN DIABETES; SPECIES SPECIFICITY; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0017349397     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0026-0495(77)90128-7     Document Type: Article

References (366)

1. Effect of weight and cell size on hormone-induced lipolysis in New Zealand obese mice and American obese hyperglycemic mice
2. Differences in the development of the obese-hyperglycemic syndrome in obob and NZO mice
3. Trois questions Naturaliste
4. The present state of knowledge of colour-heredity in mice and rats
5. The interaction of genes in development
6. Hereditary adiposity in mice
7. Les races pures et leur combinaisons chez les souris
8. Implantation and lethality of the yellow mouse
9. Evidence for the death in utero of the homozygous yellow mouse
10. Embryology of the yellow mouse
11. The fate of homozygous yellow mice
12. A note on the fate of individuals homozygous for certain color factors in mice
13. An analysis of the development of homozygous yellow mouse embryos
14. y) mouse embryos in vitro
15. A new viable yellow mutation in the house mouse
16. Aberrant regulation of the agouti pigment pattern in the viable yellow mouse
17. Body composition and coat color correlation in different phenotypes of “Viable Yellow” mice
18. New mutations
19. vy/−) mice
20. The islets of Langerhans in yellow obese mice
21. Life span of “yellow” mice fed enriched diets
22. Physiologic observations on yellow obesity in the mouse
23. Hereditary adiposity in mice and the cause of this anomaly
24. The etiologic mechanism of some forms of hormonally induced obesity
25. Lesions in “yellow” mice fed stock high-fat or high-carbohydrate diets
26. Genetic modification of homeostatic regulation in the mouse
27. Influence of certain color mutations on body size in mice rats and rabbits
28. The age factor in weight of yellow mice
29. Studies of immunoreactive insulin secretion in NZO mice in vivo
30. Genetically transmitted obesity in rodents
31. Mast cell content and fatty acid metabolism in the epididymal fat pad of obese mice
32. Cellularity of adipose depots in six strains of genetically obese mice
33. Morphological characteristics of the epididymal adipose tissue in different types of hereditary obese mice
34. Effect of diet on obesity of yellow mice in inbred lines
35. Hereditary obesity and efficient food utilization in mice
36. Food drive and satiety in yellow mice
37. Food utilization in genetic obesity of mice
38. Hereditary obesity and temperature regulation
39. Fat metabolism in experimental obesities. IX. Lipogenesis and cholesterogenesis in yellow obese mice
40. In vitro synthesis of lipids from C-14 acetate by adipose tissue from four types of obese mice
41. Physiologic and genetic influences of glucose metabolism in adipose tissue of mice
42. Lipolysis in genetically obese and diabetes-prone mice
43. Castration-induced obesity in mice
44. Obese, a new mutation in the house mouse
45. Development of the obese-hyperglycaemic syndrome in mice
46. Methodological approaches to studies of the pancreatic islets
47. Effect of a high-fat diet on obese-hyperglycaemic and non-obese Bar Harbor mice
48. The metabolism of ketones, triglyceride and monoglyceride in livers of obese hyperglycaemic mice
49. Influence of the pituitary gland from the homozygote (+/+) and heterozygote (ob/+) lean mouse on insulin secretion in vivo
50. The influence of genetic background on the expression of the obese (ob) gene in the mouse
51. Degradation of insulin in vitro by liver and epididymal adipose tissue from obese-hyperglycemic mice
52. Metabolic studies of the obese-hyperglycaemic syndrome in mice
53. Effect of diethyldithiocarbamate and other agents on mice with the obese-hyperglycemic syndrome
54. Metabolic, nutritional and endocrine studies of the hereditary obesity-diabetes syndrome of mice and mechanism of its development
55. Analysis of the blood sugar response to obese-hyperglycemic mice and normal mice to hormones Growth hormone cortison and corticotropin
56. Pathogenic aspects of the obese-hyperglycemic syndrome in mice (genotype obob). II. Extrapancreatic factors
57. The growth hormone dependent incorporation of sulphate into the costal cartilage of obese-hyperglycaemic mice of different ages
58. Immunoreactive growth hormone levels in mice with the obese-hyperglycemic syndrome (genotype obob)
59. Development of the obese-hyperglycemic syndrome in mice with a growth hormone deficiency
60. Biochemical and electron-microscopic studies on perfused livers from normal and obob mice
61. Liver perfusion of normal and obob mice: Preliminary results
62. Vascular basement membrane thickness in muscle of Spiny mice and activities of glycolysis and gluconeogenesis in the liver of animals with spontaneous and experimental diabetes and of untreated human diabetics
63. Hepatic glycolytic and gluconeogenic enzymes of the obese-hyperglycemic mouse
64. Hepatic enzyme activities of glycolysis and gluconeogenesis in diabetes of man and laboratory animals
65. Defective allosteric regulation of phosphofructokinase in genetically-obese mice
66. Regulation of Enzymes involved in gluconeogenesis
67. Activities of skeletal muscle enzymes in hereditary obese-hyperglycemic mice (genotype obob)
68. Glycogen synthetase and phosphorylase activities in different tissues of genetically obese mice
69. Organ weights in three forms of experimental obesity in the mouse
70. Some aspects of the structure and histochemistry of the adrenals in obese-hyperglycemic mice
71. Studies in obese-hyperglycemic mice
72. Biosynthesis of steroids in the Adrenals of normal and obese-hyperglycemic mice
73. The pituitary-adrenal system of the genetically obese (ob/ob) mouse
74. The effect of adrenalectomy on the development of the obese-hyperglycemic syndrome in ob/ob mice
75. Effects of adrenalectomy on the obese-hyperglycemic syndrome (obob) in mice
76. 3H-corticosterone from the serum of obese-hyperglycemic mice (gene symbol ob)
77. Elevated glucocorticoids in obese-hyperglycemic mice
78. Adrenal function and the effect of a high-fat diet on C57BL/6J and C57BL/6J-ob/ob mice
79. Function of the adrenal cortex in obese-hyperglycemic mice (gene symbol ob)
80. Evaluation of adrenal function in mice by measurement of urinary excretion of free corticoids
81. Effects of pituitary growth hormone on the insulin and hyperglycaemic-glycogenolytic factor extractable from the pancreas of obese-hyperglycaemic mice
82. Pancreatic islets in mice with the obese-hyperglycemic syndrome Lack of effect of carbutamide
83. Carbohydrate metabolism of the isolated perfused liver of normal and genetically obese-hyperglycaemic (ob/ob) mice
84. Hexokinase, glucose-6-phosphatase and phosphorylase levels in hereditarily obese-hyperglycemic mice
85. The turnover of liver glycogen in obese-hyperglycemic mice
86. Paradoxical glucagon release in obese hyperglycemic mice
87. The effect of fasting on tissue cyclic AMP and plasma glucagon in the obese hyperglycemic mouse
88. Familial diabetes mellitus in mice, associated with insulin resistance, obesity and hyperplasia of the islands of Langerhans
89. The distribution pattern of the pancreatic islet volume in normal and hyperglycaemic mice
90. Über die Pankreasinseln normal und diabetischer Fettmäuse
91. High levels of pancreatic insulin coexistent with hyperplasia and degranulation of beta cells in mice with the hereditary obese-hyperglycemic syndrome
92. Long-term effects of restricted caloric intake on pancreatic islet tissue in obese-hyperglycemic mice
93. Islet morphology and glucose metabolism in relation to the specific function of the pancreatic beta cells
94. The ultrastructure of the islets of Langerhans in normal and obese-hyerpglycemic mice
95. Quantitative studies on isolated pancreatic islets of mammals. I. Peptidase activity in normal and obese-hyperglycaemic mice
96. Histochemical studies on glucose-6-phosphatase, adenosine triphosphatase and amylo phosphorylase in the pancreatic islets of normal and obese-hyperglycaemic mice
97. Histochemical observations on the pancreatic islets in normal and obese-hyperglycemic mice
98. The activity of the islet B cells as indicated by the nuclear and nucleolar size in American obese-hyperglycemic mice
99. Use of monolayer preparations in studies of nucleolar morphology in pancreatic islet cells
100. Presence and mobilization of glycogen in mammalian pancreatic beta cells
101. Metabolism of glucose in the islets of Langerhans
102. The effect of age on some aspects of obese (ob/ob) mouse pancreatic islet morphology and metabolism
103. Effect of age on aspects of normal and obese hyperglycaemic islet morphology and metabolism
104. A combined biochemical and histological study on the islets of Langerhans in the genetically obese hyperglycaemic mouse and in the lean mouse, including observations on the effects of Streptozotocin treatment
105. The islets of Langerhans in the lean and genetically obese mouse: A related histological and histochemical study in untreated and Streptozotocin-injected animals
106. Increased circulating insulin-like activity in obese-hyperglycaemic mice
107. Am J Clin Nutr
108. Measurements of insulin activities in pancreas and serum of mice with spontaneous (“obese” and “New Zealand obese”) and induced (goldthioglucose) obesity and hyperglycemia, with considerations on the pathogenesis of the spontaneous syndrome
109. On the origin of hyperglycaemia in the obese-hyperglycaemic mouse (obob): Effect of diet on blood glucose and serum insulin in obob and goldthioglucose obese mice
110. Insulin resistance of parabiotic obese-hyperglycemic mice (obob)
111. Le syndrome récessif obésité-hyperglycémie de la souris. Ses relations possibles avec le diabète gras humain
112. Insulin resistance in genetically obese, hyperglycemic mice
113. The effect of restricted food intake on the glucose and lipid metabolism in obese-hyperglycemic mice
114. Fat metabolism in experimental obesities. VIII. Blood total lipids and ketones in four kinds of obese mice
115. Insulinaktivität, mit Antikörpern hemmbare Insulinaktivität und immunologisch messbares Insulin im Pankreas und Serum genetisch fettsüchtiger und hyperglykämischer Mäuse
116. Hyperinsulinism in mice with genetically determined obesity
117. Insulin secretion in vivo: Correlation with insulin resistance
118. Insulin secretion in experimental obesity
119. Pathogenic aspects of the obese-hyperglycemic syndrome in mice (genotype obob): I. Function of the pancreatic B-cells
120. Stammesspezifische Besonderheiten von Tiermodellen des menschlichen Diabetes mellitus vom Erwachsenentyp
121. Blood glucose and serum insulin levels in lean and genetically obese mice
122. Metabolic abnormalities in starvation diabetes
123. Biochemical and morphological studies of immunoreactive insulin secretion in spontaneous and acquired obesity and/or hyperglycemia in rodents
124. Islet function in obesity and diabetes
125. Islet function in hereditary, hypothalamic and diet-induced obesity
126. Insulin tolerance and insulin degradation in obese-hyperglycemic mice
127. Hereditary diabetes in genetically obese mice
128. Aspects of insulin resistance and insulin turn-over in mice with the obese-hyperglycaemic syndrome
129. Resistance of gluconeogenic and glycogenic pathways in obese-hyperglycemic mice
130. Glycolytic and Gluconeogenic enzyme activities in the hereditary obese-hyperglycemic syndrome and in acquired obesity
131. The metabolism of variously labelled glucose in fatty livers from mice with congenital hyperglycaemia and obesitas
132. Glucose metabolism and mobilization of fatty acids by adipose tissue from obese mice
133. Adipose tissue metabolism of obese mice on standard and high-fat diets
134. The obese hyperglycemic syndrome in mice. Metabolism of isolated adipose tissue in vitro
135. Insulin sensitivity of adipose tissue of various types of genetically obese mice
136. Metabolism in vitro of adipose tissue in obese-hyperglycemic and goldthio-glucose-treated mice
137. Insulin resistance in the muscle of obese-hyperglycemic mice (obob)
138. Comparative studies of muscle and adipose tissue metabolism in lean and obese mice
139. Métabolisme du glucose dans le tissue adipeux et les muscles des animaux présentant une obésité métabolique ou une obésité par hyperphagie
140. Insulin-wirkung auf Fettgewebe und Muskulatur normaler und fettsüchtiger Mäuse
141. Effect of insulin in vivo on diaphragm and adipose tissue of obese mice
142. The defect in insulin receptors in obese-hyperglycemic mice: A probable accompaniment of more generalized alterations in membrane glycoproteins
143. Insulin receptor defect in insulin resistance: Studies in the obese-hyperglycemic mouse
144. Insulin-receptor interaction in the obese-hyperglycemic mouse
145. Deficiency of insulin receptors in the insulin resistant obese hyperglycemic mouse
146. Insulin receptor deficiency in genetic and acquired obesity
147. Impairment of insulin binding to the fat cell plasma membrane in the obese hyperglycemic mouse
148. Thymic lymphocytes in obese (ob-ob) mice. A mirror of the insulin receptor defect in liver and fat
149. Hormonal control of intermediary metabolism in obese hyperglycemic mice. I. The sensitivity and response to insulin in adipose tissue and muscle in vitro
150. Insulin resistance of the inherently obese mouse—ob/ob
151. Obesity and insulin resistance in the obese-hyperglycemic mouse (obob)
152. Antagonism between alloxan and caffeine
153. Effect of alloxan on obese-hyperglycaemic mice
154. Stoffwechsel der Bar Harbor obese Maus (C57BL/6J-ob) bei Insulinbehandlung und Hemmung der endogenen Insulin-sekretion
155. The cause of insulin resistance in obesity
156. Amelioration of insulin resistance in obese mice
157. The effect of oxytetracycline on insulin resistance in obese mice
158. Increased insulin binding capacity of liver membranes from diabetic Chinese hamsters
159. Fat metabolism in three forms of experimental obesity I Body composition
160. The effect of restricted food intake on the life span of genetically obese mice
161. Effect of food restriction on body composition of hereditary obese mice
162. Induction of obesity in obese-hyperglycaemic mice on normal food intake
163. Effect of caloric restriction on body weight loss and body fat utilization in obese hyperglycemic mice (obob)
164. Body composition of mice with goldthioglucose and hereditary obesity after weight reduction
165. Gross body composition of genetically obese mice and normal littermates
166. Effects of chronic treatment with carbutamide on distribution and biosynthesis of fatty acids and cholesterol in obese-hyperglycemic mice
167. Hypercholesterolemia in the hereditary obese-hyperglycemic syndrome of mice
168. Plasma lipoproteins and the synthesis and turnover of plasma triglyceride in normal and genetically obese mice
169. Levels of serum cholesterol in obese mice
170. Growth of adipose and lean tissue mass in hindlimbs of genetically obese mice during preobese and obese phases of development
171. Abnormalities in lipogenesis and triglyceride secretion by perfused livers of obese-hyperglycaemic (ob/ob) mice: Relationship with hyperinsulinaemic
172. Metabolism in vitro of adipose tissue in obese-hyperglycemic and goldthio-glucose-treated mice II Metabolism of pyruvate and acetate
173. Studies of pyruvate and acetate metabolism in the hereditary obesity-diabetes syndrome of mice
174. Influence of glucose on the in vitro acetate metabolism in the epididymal adipose tissue of obese-hyperglycemic mice
175. Oxidation of acetate glucose or glycine to carbon dioxide in mice exhibiting the hereditary obesity syndrome
176. Métabolisme in vitro du tissue adipeux. VI. Métabolisme in vitro de l'acétate dans le tissue adipeux épididymaire de deux souris obèses jeunes: La souris obèses-hyperglycémique de Bar Harbor (O-H) et la souris Néo-Zélandaise (NZO)
177. 14C
178. 14C)
179. Les obésités expérimetates
180. 14 in obese-hyperglycemic mice
181. Studies on lipogenesis in vivo Fatty acid and cholesterol synthesis in hyperglycaemic-obese mice
182. Biochimie de la souris obèse-hyperglycémique (O-H) de Bar Harbor
183. The obese-hyperglycemic syndrome in Bar Harbor mice
184. Hormone-substrate responses to total fasting in lean and obese mice
185. The metabolic response of lean and obese mice to prolonged fasting
186. Fat metabolism in three forms of experimental obesity II Acetate incorporation
187. Fat metabolism in three forms of experimental obesity IV “Instantaneous” rates of lipogenesis in vivo
188. Fat metabolism in three forms of obesity. V. Hepatic lipogenesis in vitro
189. The Regulation of the Adipose Tissue Mass, Proceedings of the Fourth International Meeting of Endocrinology
190. Lipase and glycerokinase activities in the adipose tissue of obese-hyperglycaemic mice
191. Glycerol kinase activity in isolated fat cells of BHob mice
192. Regulation of glycerolkinase by insulin in Fettzellen und Leber von genetisch fettsüchtigen Mäusen (BH-ob)
193. Regulation of glycerolkinase by insulin in isolated fat cells and liver of Bar Harbor obese mice
194. Adipose tissue glycerokinase activity in genetic and acquired obesity in rats and mice
195. Glycerolkinase activity in white adipose tissue of obese-hyperglycaemic mice
196. Alpha-glycerophosphate oxydation in the tissues of obese hyperglycemic mice and nonobese controls
197. Enzymatic activities in tissues of obese-hyperglycemic mice
198. Adaptive enzyme response in adipose tissue of obese hyperglycemic mice
199. Adipose and liver tissue enzyme profiles in obese hyperglycemic mice
200. Citrate cleavage enzyme in livers of obese and nonobese mice
201. Liver acetyl CoA carboxylase and fatty acid synthetase: Relative activities in the normal state and in hereditary obesity
202. Adaptive response of hepatic acetyl-CoA carboxylase to dietary alterations in genetically obese mice and their lean controls
203. Synthesis and degradation of liver acetyl coenzyme A carboxylase in genetically obese mice
204. Desaturation of stearic acid by liver and adipose tissue from obese-hyperglycaemic mice (ob/ob)
205. Insulin and liver lipid metabolism
206. Adipose tissue and liver lipogenesis and triglyceride secretion in obese-hyperglycemic (ob/ob) mice: Possible relationship with hyperinsulinemia
207. In vivo studies on lipogenesis in obese hyperglycaemic (ob/ob) mice: Possible role of hyperinsulinaemia
208. Acetate metabolism in isolated epididymal adipose tissue from obese-hyperglycemic mice of different ages
209. Acetate metabolism of the epididymal adipose tissue in the presence of hydrocortisone. In vitro studies with normal and obese-hyperglycemic mice
210. Obésité héréditaire chez la souris: Syndrome obésité-hyperglycémie. Contribution à lo biochimie des obésitées expérimentales
211. Behavior of transplanted adipose tissue of hereditarily obese mice
212. Composition of adipose tissue in several forms of obesity
213. Morphological characteristics of the epididymal adipose tissue in mice with obesity induced by goldthioglucose
214. Morphological characteristics of the epididymal adipose tissue in normal and obese-hyperglycemic mice
215. Postnatal growth of the epididymal adipose tissue in yellow obese mice
216. Investigations on cell proliferation in white adipose tissue of obese hyperglycemic mice (C57BL/6J obob)
217. Morphological characteristics of the epididymal adipose tissue in starved American obese-hyperglycemic mice
218. Pathological changes in adipose tissue of obese mice
219. Epididymal fat pad alterations in mice with spontaneous obesity and diabetes and with chemically induced obesity
220. Cellularity of the different cell compartments in white adipose tissue of mice in chronic starvation, refeeding and in two types of obesity
221. Fatty acid mobilization in obese mice
222. The influence of epinephrine and fasting on adipose tissue content and release of free fatty acids in obese-hyperglycemic and lean mice
223. An analysis of the lipolysis in vitro of obese-hyperglycaemic and diabetic mice
224. Effect of obese and diabetes mutations on lipolysis in mice
225. Enlargement of epididymal adipocytes in relation to hyperinsulinemia in obese hyperglycemic mice (ob/ob)
226. Failure of thermogenesis and effect of high frequency electromagnetic waves in the hereditary obese-hyperglycemic syndrome
227. Imperfect homeothermia in the hereditary obese-hyperglycemic syndrome of mice
228. Use of high frequency electromagnetic waves in the study of thermogenesis
229. Sensitivity to cold in the hereditary obese-hyperglycemic syndrome of mice
230. Role of the thyroid in the development of the obese-hyperglycemic syndrome in mice (ob/ob)
231. Locomotor activity of various types of genetically obese mice
232. Growth pattern and behavioral traits associated with the development of the obese-hyperglycemic syndrome in mice (ob/ob)
233. Activity and body weight relationships in genetically obese animals
234. Genetic traumatic and environmental factors in the etiology of obesity
235. Central and sensory control of food intake in genetically obese mice
236. Ventromedial hypothalamus and hyperphagia in hyperglycemic obese mice
237. Alterations in the fatty acid composition of depot fat associated with obesity
238. Parabiosis and transplantation experiments in hereditary obese mice
239. Effects of parabiosis of obese with diabetes and normal mice
240. Diabetes, a new mutation in the mouse
241. The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL/KsJ and C57BL/6J strains
242. Diabetes in the mouse due to two genes—A bibliography
243. Adipose, a new inherited obesity of the mouse
244. Features of the “adipose” mouse
245. The reproductive system of the adipose mouse
246. Genetic control of metabolism: Enzyme studies of the obese and adipose mutants in the mouse
247. Influence of genetic background on the expression of mutations at the diabetes locus in the mouse. II. Studies on background modifiers
248. Studies in the diabetic mutant mouse. IV. DBM, a modified diabetic mutant produced by outcrossing of the original strain
249. Long-term studies of feeding behavior of obese diabetic and viable yellow mutant mice under ad lib and operant conditions
250. Content of adenosine 3′,5′-cyclic monophosphate in the pancreatic islets of mice with a hereditary defect of insulin secretion
251. Influence of the mutation “Diabetes” on insulin release and islet morphology in mice of different genetic backgrounds
252. The insulin secretory defect in genetically diabetic mice
253. Studies with the mutations, diabetes in the mouse
254. Lésions physiologiques et morphologiques caractérisant le diabète par mutation (db) chez la souris
255. Studies in the diabetic mutant mouse. V. Glucose tolerance in mice homozygous and heterozygous for the diabetes (db) gene
256. Studies in the diabetic mutant mouse. III. Physiological factors associated with alterations in beta cell proliferation
257. The influence of age and diatary conditions on diabetes in the db mouse
258. Hyperinsulinemia in pre-weaning diabetes (db) mice
259. The mutation, diabetes in the mouse
260. Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria
261. Capillary basement membranes of muscle in diabetic mice (genetic and virally induced)
262. Hepatic carbohydrate metabolism in the genetically diabetic (db/db) mice
263. Glucose metabolism and insulin sensitivity in livers of genetically diabetic (db/db) mice
264. Abnormalities in hepatic enzyme activities during development of diabetes in db mice
265. Tiermodelle in der Diabetesforschung: metabolische und hormonelle Besonderheiten
266. Hyperglucagonemia of the isolated perfused pancreas of diabetic mice (db/db)
267. Insulin secretion in early diabetic animals: In vivo studies
268. Insulin secretion in mice with hereditary diabetes
269. Beta cell proliferation and DNA synthesis in diabetic mutant mice
270. Pancreatic islet studies in diabetic mutant mice
271. Effects of diet on pancreatic beta cell replication in mice with hereditary diabetes
272. Androgen effect on genetic and goldthio-glucose-induced obesity
273. The lipolytic system in adipose tissue of Toronto-KK and C57BL/KsJ diabetic mice. Adenylate cylase, phophodiesterase and protein kinase activities
274. Effects of parabiosis of normal with genetically diabetic mice
275. The effects of hypothalamic lesions in genetically diabetic mice
276. The response of “obese” (ob/ob) and “diabetic” (db/db) mice to treatments that influence body temperature
277. Inbred strains resulting from Japanese mice
278. A diabetic strain of the mouse
279. Diabetes in the KK mouse
280. General survey of diabetic features of yellow KK mice
281. y mice
282. Induction of overt diabetes in KK mice by dietary means
283. Studies on diabetogenic action of obesity in mice: Congenital insulin resistance of KK mice
284. 2 offspring of the cross between KK and C57BL/6J mice
285. Studies on a diabetic (KK) strain of the mouse
286. A comparison of the modes of inheritance of diabetes in the Chinese hamster and the KK mouse
287. Further characterization of diabetes-like abnormalities in the T-KK mouse
288. Effect of several hormones on the tolerance to glucose in the non-diabetic stage of KK mice
289. Related factors in the progression of microangiopathy in KK mice
290. Comparison of diabetes in the Chinese hamster, KK mouse and db mouse
291. Studies of vascular and other lesions in KK mice
292. Glomerular lesions in a strain of genetically diabetic mice
293. Glomerular changes in mice with spontaneous hereditary diabetes
294. Diabetes in the Toronto-KK hybrid mouse. Abnormalities in liver and pancreatic islets of Langerhans
295. Alterations of hepatic enzyme activities in KK and yellow KK mice with various diabetic states
296. Metabolic disturbance of KK mice in chemical diabetes
297. Induction of overt diabetes in KK mice by dietary means
298. Streptozotocin resistance of the genetically diabetic KK mouse
299. Congenitally impaired hormone sensitivity of the adipose tissue of spontaneously diabetic mice, KK. Validity of thrifty genotype in KK mice
300. Decreased binding of insulin to liver plasma membrane receptors in hereditary diabetic mice
301. Ultra-structure of glomerular lesions in KK mice
302. Studies on a diabetic (KK) strain of the mouse. With special reference to the histology of the endocrine organs
303. Electron microscopic studies on the pancreatic islets of KK mice and Sekoke (spontaneous diabetes mellitus) carp
304. High secretory activity in the pancreatic B cells of a diabetic strain of the Japanese mouse
305. Cytological and histological studies on the pancreatic islets of a diabetic strain of the mouse
306. Enzyme morphological studies on the pancreatic islets of a diabetic (KK) strain of the mouse
307. Lipogenic enzymes in two types of genetically obese animals, fatty rats and yellow KK mice
308. Studies on lipogenesis in hereditary obese-hyperglycemic mice (KK strain)
309. Metabolic disturbance of KK mice in overt diabetes
310. Estimation of adeno-hypophyseal growth hormone content in the diabetic “KK” mouse strain by acrylamide gel electrophoresis
311. A new strain of mice with hereditary obesity
312. Genetics of animals with spontaneous diabetes
313. Origin of inbred NZ mouse strains
314. The New Zealand strains of obese mice Their response to stilboestrol and to insulin
315. Growth characteristics, glucose tolerance and insulin sensitivity of New Zealand obese mice
316. Investigation on carbohydrate and fat metabolism of the New Zealand obese mice under the influence of various diets
317. Tierexperimentelle Untersuchungen zum Problem der Insulin-Resistenz bei Adipositas und Diabetes mellitus. Pathogenese des fettsüchtig-hyperglykamischen Sydroms
318. Über den Einfluss von Insulin auf die Alanin-gluconeogenese in der isoliert perfundierten Leber von New Zealand obese mice
319. Enzymatic aspects of the stimulation of the B-cells by glucose
320. Measurements of the enzymatic activities required for ATP formation by glycolysis in the pancreatic islets of hyperglycemic mice (NZO)
321. On the enzymatic activity of the pancreatic islets and acini in New Zealand obese mice
322. The enzymatic activities of the initial glycolytic steps in pancreatic islets and acini
323. On the glycolytic conversion of triosephosphates in the pancreatic islets and acini of NZO mice
324. Untersuchungen des Glukose- und Fettstoffwechsels bei hereditär fettsüchtigen und hyperglykämischen Mäusen. III. Hormonelle Effekte auf die Fettsäuren des Fettgewebes bei C57BL/6J-ob und New Zealand obese Mäusen
325. Selective defect in insulin release in one form of spontaneous laboratory diabetes
326. Defective insulin secretory response to glucose in the New Zealand obese mouse. Improvement with restricted diet
327. Defective insulin secretion in the NZO mouse: In vivo studies
328. On the long-term effects of chlorpentazide in mice with hereditary hyperglycemia (NZO)
329. Untersuchungen des Glukose- und Fettstoffwechsels bei hereditär fettsüchtigen und hyperglykämischen Mäusen. II. Glukose- und Fettstoffwechsel bei New Zealand obese (NZO) Mäusen
330. Further studies on the amelioration of the characteristics of New Zealand obese (NZO) mice following implantation of islets of Langerhans
331. Studies on implanted islets of Langerhans: Normalization of blood glucose concentration, blood insulin concentration and weight gain in New Zealand obese mice
332. Return to normal of blood glucose, plasma insulin and weight gain in New Zealand obese mice after implantation of islets of Langerhans
333. Return to normal of blood glucose, plasma-insulin, and weight gain in New Zealand obese (NZO) mice after implantation of streptozotocin treated islets of Langerhans
334. Insulin receptor of the New Zealand obese (NZO) mouse: Changes following the implantation of islets of Langerhans
335. The control of insulin receptors in the New Zealand obese mouse
336. Pancreatic and serum insulin in the New Zealand strain of obese mice
337. Metabolism in the New Zealand strain of obese mice
338. Participation du foie et du tissue adipeux épididymaire à l'obésité de la souris obèse Néo-Zélandaise (NZO) agée d'un an
339. Métabolisme “in vitro” du foie et du tissue adipeux épididymaire de la souris ebèse Néo-Zélandaise
340. Influence of diet on the metabolic syndrome of obesity
341. Dietary-induced hypertrophic-hyperplastic obesity in mice
342. The endocrine status of obese mice
343. 14 1-acetate and release of free fatty acids
344. Comparative investigations on lipolysis and reesterification in adipose tissue of man and various species of mice
345. The control of lipolysis in obese mice
346. Lipolysis and adenosine 3′5′-cyclic monophosphate in adipose tissue of the New Zealand obese mouse
347. Plasma growth hormone in the New Zealand obese mouse
348. Spontandiabetes bei Tieren
349. Spontaneous hyperglycemia and obesity in laboratory rodents
350. Spontaneous diabetes and/or obesity in laboratory rodents
351. Possible chemical defects in diabetes mellitus in man and hereditary diabetes mellitus in animals
352. Spontaneous hereditary diabetes in laboratory animals
353. Zur Pathogenese des hyperglykämischen Syndroms: Untersuchungen an spontan hyperglykämischen, “diabetischen” Tieren
354. Le diabète spontané chez l'animal. Considérations sur la pathogénése du syndrome aigu et sur la morphologie des lésions du syndrome chronique
355. Spontaneous hyperglycemia and/or obesity in laboratory rodents. An example of the possible usefulness of animal disease models with both genetic and environmental components
356. Experimenteller Diabetes: Untersuchungen zur Pathogenese des hyperglykämischen Syndroms
357. The pathogenesis of diabetes mellitus
358. On the pathogenesis of diabetes mellitus: Possible usefulness of spontaneous hyperglycemic syndromes in animals
359. Experimental and spontaneous diabetes in animals: What is their relevance to human diabetes mellitus?
360. Laboratory animals with spontaneous diabetes and/or obesity: Suggested suitability for the study of spontaneous atherosclerosis
361. Endocrine-metabolic anomalies in rodents with hyperglycemic syndromes of hereditary and/or environmental origin
362. Mouse Newslett